Found 7 matching trials
Tislelizumab in Combination With TACE in Advanced Hepatocellular Carcinoma PHASE2 A multicentric, open-label, single-arm prospective study to assess the effi...
Show More Location
Centre of Interventional Radiology and Vascular Surgery, Department of Radiology, Zhongda Hospital, Southeast University
Learn More & Join Trial
Safety and Efficacy of LVD + C-TACE + Tis/Len for Unresectable Right-Liver HCC NA This study evaluates a novel "Dual-Conversion" strategy (mechanical volume ...
Show More Location
West China Hospital, Sichuan University
Learn More & Join Trial
Intraarterial Therapies Plus Tislelizumab Plus Lenvatinib Versus Tislelizumab Plus Gemcitabine-Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma PHASE3 This is a phase III, multicenter, open-label, randomized controlled trial d...
Show More Location
The First Affiliated Hospital, Sun Yat-sen University
Learn More & Join Trial
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC N/A The purpose of this study is to evaluate the safety and efficacy of transar...
Show More Learn More & Join Trial
Efficacy and Safety of TACE in Combination With ICIs for HCC: a Real-world Study N/A The purpose of this study is to evaluate the safety and efficacy of transar...
Show More Learn More & Join Trial
Survival Analysis: TACE vs. Combination Therapy in HCC N/A This retrospective observational study aimed to assess potential improvemen...
Show More Location
First Affiliated Hospital, Medical College of Zhejiang University
Learn More & Join Trial
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC N/A The purpose of this study is to evaluate the safety and efficacy of transar...
Show More Learn More & Join Trial